PA

Perceptive Advisors Portfolio holdings

AUM $5.46B
1-Year Est. Return 264.28%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+264.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.46B
AUM Growth
+$2B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
131
New
Increased
Reduced
Closed

Top Buys

1
+$80.3M
2
+$65.6M
3
+$61.6M
4
EXAS
Exact Sciences
EXAS
+$59M
5
DYN icon
Dyne Therapeutics
DYN
+$55.6M

Top Sells

1
+$127M
2
+$101M
3
+$80M
4
VRNA
Verona Pharma
VRNA
+$55.9M
5
AKRO
Akero Therapeutics
AKRO
+$53.9M

Sector Composition

1 Healthcare 99.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXEO icon
101
Lexeo Therapeutics
LXEO
$512M
$1.39M 0.03%
139,835
CPIX icon
102
Cumberland Pharmaceuticals
CPIX
$48.3M
$1.36M 0.02%
+341,087
MDLN
103
Medline Inc
MDLN
$38.7B
$1.18M 0.02%
+28,000
PTN
104
Palatin Technologies
PTN
$39.9M
$1.08M 0.02%
+70,000
LENZ
105
LENZ Therapeutics
LENZ
$319M
$800K 0.01%
+50,000
BDSX icon
106
Biodesix
BDSX
$133M
$739K 0.01%
108,694
NVNO icon
107
enVVeno Medical
NVNO
$7.67M
$564K 0.01%
50,258
IOVA icon
108
Iovance Biotherapeutics
IOVA
$1.59B
$417K 0.01%
+152,714
RVMDW icon
109
Revolution Medicines Inc Warrant
RVMDW
$59.9M
$235K ﹤0.01%
250,000
ENSC icon
110
Ensysce Biosciences
ENSC
$4.64M
$79.7K ﹤0.01%
86,666
SRZNW icon
111
Surrozen Inc Warrant
SRZNW
$61.3K
$3.33K ﹤0.01%
166,666
APYX icon
112
Apyx Medical
APYX
$166M
– –
-150,000
BHVN icon
113
Biohaven
BHVN
$1.65B
– –
0
AKRO
114
DELISTED
Akero Therapeutics
AKRO
– –
-1,135,766
CAPR icon
115
Capricor Therapeutics
CAPR
$2.01B
– –
0
INSM icon
116
Insmed
INSM
$31.2B
– –
-702,130
JANX icon
117
Janux Therapeutics
JANX
$962M
– –
-292,686
LYRA
118
DELISTED
LYRA THERAPEUTICS INC
LYRA
– –
-229,382
MRUS
119
DELISTED
Merus
MRUS
– –
-1,353,093
PYXS icon
120
Pyxis Oncology
PYXS
$104M
– –
-1,178,307
QURE icon
121
uniQure
QURE
$1.1B
– –
-20,000
SCPH
122
DELISTED
scPharmaceuticals
SCPH
– –
-583,142
SPRY icon
123
ARS Pharmaceuticals
SPRY
$812M
– –
0
TRIB
124
Trinity Biotech
TRIB
$14.1M
– –
-1,790,000
VKTX icon
125
Viking Therapeutics
VKTX
$4.08B
– –
-105,597
2 3 4
5
6